Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CRISP3 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of CRISP3 mRNA | increases expression | 19619570
|
C116926 |
rofecoxib |
rofecoxib results in increased expression of CRISP3 mRNA | increases expression | 17070997
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CRISP3 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CRISP3 mRNA | increases expression | 19619570
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of CRISP3 mRNA | increases expression | 17982090
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.47 | 14514962 11752688 15322242 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.17 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.01 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.34 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
4.57 | 16690336 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.47 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.00 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.90 | 17289903 16675129 14630087 12948864 17261762 19861407 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.09 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.56 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.03 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.24 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
5.10 | 11698051 17991707 17936198 16867261 18200517 18023891 16804969 16782535 16474422 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.54 | 17276891 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
3.35 | 12902858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 10048152 15322242 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.78 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.62 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.05 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.62 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.22 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
10.67 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
10.67 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.02 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.86 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
10.86 | 17994277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.32 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.51 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.76 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.45 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.76 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.47 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.77 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.02 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.03 | 12878042 12200463 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.70 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.21 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
12.39 | 15831440 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
12.39 | 17994277 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.83 | 11245490 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.76 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.78 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.32 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.80 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
3.80 | 17565644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.80 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.33 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.79 | 11807958 16891317 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.21 | 19453300 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.34 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.59 | 16810080 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.36 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
11.20 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
11.20 | 14600291 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.59 | 16690336 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.31 | 19401270 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
6.11 | 18165598 16678543 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.66 | 17698068 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.97 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.07 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.82 | 11222880 11118676 11896295 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.31 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.02 | 16740699 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.35 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.20 | 16192470 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.62 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.41 | 19048282 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.32 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.97 | 15886252 |